Phase I study of mitonafide with a 3-day administration schedule: Early interruption due to severe central nervous system toxicity

  1. Díaz-Rubio, E.
  2. Martín, M.
  3. López-Vega, J.M.
  4. Casado, A.
  5. Benavides, A.
Aldizkaria:
Investigational New Drugs

ISSN: 0167-6997,  1573-0646

Argitalpen urtea: 1994

Alea: 12

Zenbakia: 4

Orrialdeak: 277-281

Mota: Artikulua

DOI: 10.1007/BF00873041 GOOGLE SCHOLAR
Datuen iturria: Scopus